Amlodipine plus atorvastatin is cost-effective compared to atenolol plus atorvastatin, amlodipine or atenolol alone: The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

被引：0

作者：

Lindgren, P. ^{[1
]}

Buxton, M. ^{[2
]}

Kahan, T. ^{[3
]}

Poulter, N. ^{[4
]}

Dahlof, B. ^{[5
]}

Sever, P. S. ^{[3
]}

Wedel, H. ^{[6
]}

Jonsson, B. ^{[7
]}

机构：

[1] European Hlth Econ, Stockholm, Sweden

[2] Brunel Univ, Uxbridge UB8 3PH, Middx, England

[3] Danderyd Hosp, Karolinska Inst, Stockholm, Sweden

[4] Univ London Imperial Coll Sci Technol & Med, London, England

[5] Sahlgrens Univ Hosp, Gothenburg, Sweden

[6] Nord Sch Publ Hlth, Gothenburg, Sweden

[7] Stockholm Sch Econ, S-11383 Stockholm, Sweden

来源：

EUROPEAN HEART JOURNAL | 2007年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：857 / 857

页数：1

共 34 条

[1] The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone Results from ASCOT
Lindgren, Peter
Buxton, Martin
Kahan, Thomas
Poulter, Neil R.
Dahlof, Bjorn
Sever, Peter S.
Wedel, Hans
Jonsson, Bengt
PHARMACOECONOMICS, 2009, 27 (03) : 221 - 230
[2] The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy AloneResults from ASCOT
Peter Lindgren
Martin Buxton
Thomas Kahan
Neil R. Poulter
Björn Dahlöf
Peter S. Sever
Hans Wedel
Bengt Jönsson
PharmacoEconomics, 2009, 27 : 221 - 230
[3] An amlodipine-based regimen is cost-effective compared to an atenolol-based regimen:: Results from the Anglo-Scandinavian cardiac outcomes trial
Lindgren, P.
Buxton, M.
Kahan, T.
Poulter, N. R.
Dahlof, B.
Sever, P. S.
Wedel, H.
Jonsson, B.
JOURNAL OF HYPERTENSION, 2007, 25 : S137 - S137
[4] Cost-effectiveness of multi-drug regimen of amlodipine plus atorvastatin based on the anglo-scandinavian cardiac outcomes trial (ASCOT):: An economic sub-analysis
Koren, Michael
Lindgren, Peter
Buxton, Martin
Kahan, Thomas
Poulter, Neil
Dahlof, Bjorn
Sever, Peter
Wedel, Hans
Tang, Simon S.
Jonsson, Bengt
CIRCULATION, 2007, 115 (21) : E568 - E568
[5] The impact of age on blood pressure reduction due to atenolol and amlodipine in the blood-pressure lowering arm of the anglo-scandinavian cardiac outcomes trial
Poulter, Neil R.
Chang, Choon-Lan
Sever, Peter S.
Dahlot, Bjorn
Hans, Wedel
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 371A - 371A
[6] Long-term anti-hypertensive treatment with amlodipine/perindopril results in lower carotid IMT than with atenolol/bendroflumethiazide in the Anglo Scandinavian Cardiac Outcomes Trial (ASCOT)
Thompson, David
Hughes, Alun
Kok, Hong Kuan
Vangjeli, Ciara
Mayet, Jamil
Thom, Simon
Stanton, Alice
JOURNAL OF HUMAN HYPERTENSION, 2016, 30 (10) : 636 - 636
[7] Prevention of coronary and stroke events with atorvastatin in hypertensive patients - ASCOT-LLA (the Anglo-Scandinavian cardiac outcomes trial - Lipid lowering arm)
Lyakishev, AA
KARDIOLOGIYA, 2003, 43 (05) : 75 - 75
[8] Cost-effectiveness of Atorvastatin plus Amlodipine versus Atorvastatin plus Atenolol in hypertensive patients without previous coronary heart disease, normal to mildly elevated cholesterol levels and at least 3 cardiovascular risk factors
F Bobadilla, J.
Merikle, E.
Garcia, M.
Darba, J.
Sanchez, C.
VALUE IN HEALTH, 2007, 10 (06) : A415 - A416
[9] Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA) - a multicentre randomised controlled trial
Radziemski, Artur
ARTERIAL HYPERTENSION, 2005, 9 (06): : 499 - 503
[10] Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events:: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm (ASCOT-LLA)
Lindgren, P
Buxton, M
Kahan, T
Poulter, NR
Dahlöf, B
Sever, PS
Wedel, H
Jönsson, B
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (01): : 29 - 36

← 1 2 3 4 →